Icares Medicus Inc (6612) - Total Assets
Based on the latest financial reports, Icares Medicus Inc (6612) holds total assets worth NT$3.18 Billion TWD (≈ $100.19 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Icares Medicus Inc (6612) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Icares Medicus Inc - Total Assets Trend (2017–2025)
This chart illustrates how Icares Medicus Inc's total assets have evolved over time, based on quarterly financial data. Check 6612 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Icares Medicus Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Icares Medicus Inc's total assets of NT$3.18 Billion consist of 53.5% current assets and 46.5% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 14.4% |
| Accounts Receivable | NT$344.39 Million | 10.8% |
| Inventory | NT$423.64 Million | 13.3% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$0.00 | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2017–2025)
This chart illustrates how Icares Medicus Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Icares Medicus Inc (6612) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Icares Medicus Inc's current assets represent 53.5% of total assets in 2025, a decrease from 79.3% in 2017.
- Cash Position: Cash and equivalents constituted 14.4% of total assets in 2025, down from 54.5% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2017.
- Asset Diversification: The largest asset category is inventory at 13.3% of total assets.
Icares Medicus Inc Competitors by Total Assets
Key competitors of Icares Medicus Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
AVE Science & Technology Co Ltd
SHG:688067
|
China | CN¥611.46 Million |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
Icares Medicus Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.04 | 2.46 | 5.31 |
| Quick Ratio | 1.53 | 1.87 | 4.71 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$867.88 Million | NT$839.52 Million | NT$370.79 Million |
Icares Medicus Inc - Advanced Valuation Insights
This section examines the relationship between Icares Medicus Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.85 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 5.7% |
| Total Assets | NT$3.18 Billion |
| Market Capitalization | $108.43 Million USD |
Valuation Analysis
Below Book Valuation: The market values Icares Medicus Inc's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Icares Medicus Inc's assets grew by 5.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Icares Medicus Inc (2017–2025)
The table below shows the annual total assets of Icares Medicus Inc from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | NT$3.18 Billion ≈ $100.19 Million |
+5.71% |
| 2024-12-31 | NT$3.01 Billion ≈ $94.77 Million |
+57.61% |
| 2023-12-31 | NT$1.91 Billion ≈ $60.13 Million |
+82.92% |
| 2022-12-31 | NT$1.04 Billion ≈ $32.87 Million |
+8.03% |
| 2021-12-31 | NT$965.87 Million ≈ $30.43 Million |
+13.89% |
| 2020-12-31 | NT$848.05 Million ≈ $26.72 Million |
+7.07% |
| 2019-12-31 | NT$792.06 Million ≈ $24.95 Million |
+28.29% |
| 2018-12-31 | NT$617.38 Million ≈ $19.45 Million |
+53.78% |
| 2017-12-31 | NT$401.48 Million ≈ $12.65 Million |
-- |
About Icares Medicus Inc
ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, United Kingdom, Japan, Spain, China, Germany, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataract… Read more